Medicare Enrolled

Dr. Richard Gan, MD

Neurology · Edison, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
34-36 PROGRESS ST, Edison, NJ 08820
9087576633
In practice since 2006 (19 years)
NPI: 1063588481 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gan

Dr. Richard Gan is a neurology specialist in Edison, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gan performed 293 Medicare services across 215 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gan received a total of $14,740 from 69 pharmaceutical and/or device companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 293 Medicare services $14,740 industry payments

Medicare Practice Summary

Medicare Utilization ↗
293
Medicare services
Bottom 28% in NJ for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
215
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
166 $103 $434
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
58 $50 $308
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
56 $139 $563
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $61 $310
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,740
Total received (2018-2024)
Avg $2,106/year across 7 years
Top 20% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
930
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,631 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$108 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,493
2023
$2,292
2022
$2,442
2021
$2,242
2020
$2,106
2019
$1,809
2018
$1,356

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$415
Novartis Pharmaceuticals Corporation
$364
Neurocrine Biosciences, Inc.
$270
Medtronic, Inc.
$199
Biogen, Inc.
$161
MDD US Operations, LLC
$147
Teva Pharmaceuticals USA, Inc.
$137
Amneal Pharmaceuticals LLC
$129
Lilly USA, LLC
$94
ACADIA Pharmaceuticals Inc
$91
Eisai Inc.
$85
UCB, Inc.
$70
Lundbeck LLC
$67
PFIZER INC.
$48
GE HEALTHCARE
$40
Celgene Corporation
$33
Alexion Pharmaceuticals, Inc.
$32
Otsuka America Pharmaceutical, Inc.
$23
Genentech USA, Inc.
$20
Amgen Inc.
$19
Vanda Pharmaceuticals Inc.
$17
Sumitomo Pharma America, Inc.
$16
Acorda Therapeutics, Inc
$16
Top 3 companies account for 42.0% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,883
Novartis Pharmaceuticals Corporation
$1,675
ABBVIE INC.
$926
Teva Pharmaceuticals USA, Inc.
$924
UCB, Inc.
$712
Neurocrine Biosciences, Inc.
$629
Genentech USA, Inc.
$494
Amgen Inc.
$464
ACADIA Pharmaceuticals Inc
$435
Amneal Pharmaceuticals LLC
$335
Lilly USA, LLC
$326
Alexion Pharmaceuticals, Inc.
$320
MDD US Operations, LLC
$310
EMD Serono, Inc.
$293
Eisai Inc.
$282
Celgene Corporation
$273
GENZYME CORPORATION
$268
Janssen Pharmaceuticals, Inc
$262
Supernus Pharmaceuticals, Inc.
$245
Lundbeck LLC
$242
SK Life Science, Inc.
$226
Avanir Pharmaceuticals, Inc.
$225
Medtronic, Inc.
$199
Kyowa Kirin, Inc.
$194
Acorda Therapeutics, Inc
$150
AbbVie Inc.
$148
Allergan, Inc.
$141
Biohaven Pharmaceuticals, Inc.
$130
PFIZER INC.
$119
Upsher-Smith Laboratories LLC
$103
ARGENX US, INC.
$103
Akcea Therapeutics, Inc.
$102
Currax Pharmaceuticals LLC
$101
EISAI INC.
$95
Grifols USA, LLC
$94
Sunovion Pharmaceuticals Inc.
$86
Adamas Pharmaceuticals, Inc.
$84
Mallinckrodt Hospital Products Inc.
$76
IMPEL PHARMACEUTICALS INC.
$71
E.R. Squibb & Sons, L.L.C.
$68
Otsuka America Pharmaceutical, Inc.
$66
GE HEALTHCARE
$65
Boston Scientific Corporation
$59
Biohaven Pharmaceutical Holding Company Ltd.
$50
ARBOR PHARMACEUTICALS, INC.
$49
Mallinckrodt Enterprises LLC
$48
Mallinckrodt LLC
$45
Jazz Pharmaceuticals Inc.
$44
Bayer HealthCare Pharmaceuticals Inc.
$43
Neurelis, Inc.
$42
Arbor Pharmaceuticals, Inc.
$41
Allergan Inc.
$39
GE HealthCare
$39
Validus Pharmaceuticals LLC
$32
Avion Pharmaceuticals
$27
CATALYST PHARMACEUTICALS, INC.
$25
Aprecia Pharmaceuticals, LLC
$25
Mylan Pharmaceuticals Inc.
$24
AstraZeneca Pharmaceuticals LP
$21
Vanda Pharmaceuticals Inc.
$17
Sumitomo Pharma America, Inc.
$16
Assertio Therapeutics, Inc.
$16
Banner Life Sciences, LLC
$16
Horizon Therapeutics plc
$15
GE Healthcare
$14
Collegium Pharmaceutical, Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
Zyla Life Sciences
$13
SANOFI-AVENTIS U.S. LLC
$11
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · Betaseron · Briviact · CONTRAVE · COPAXONE · CREXONT · DUOPA · Dhivy · ELYXYB - celecoxib · EMGALITY · Edarbi · Enspryng · Equetro · FABRAZYME · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gralise · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LINQ II · LYRICA · Leqembi · MAYZENT · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PONVORY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · Spritam · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vimpat · XADAGO · XARELTO · Xyrem · ZEPOSIA · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Edison?
Compare neurologists in the Edison area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
667
Per 100K population
77.4
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gan performed 166 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gan receive payments from pharmaceutical companies?
Yes. Dr. Gan received a total of $14,740 from 69 companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gan's costs compare to other neurologists in Edison?
Dr. Gan's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →